Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?

7 Nov 2019

Abstract excerpt

OBJECTIVES: To give an overview of the genetic and structural abnormalities occurring in fetuses with nuchal translucency (NT) measurement exceeding the 95th percentile at first-trimester screening and to investigate which of these abnormalities would be missed if cell-free fetal DNA (cfDNA) were used as a first-tier screening test for chromosomal abnormalities. METHODS: This is a national study including 1901...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Pregnancy and preeclampsia studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31697852
DOI: 10.1002/pd.5590

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?PMID 31697852Read ↗

Can Cell-Free DNA Testing Suffice for Isolated Fetal Nuchal Translucency Between the 95th – 99th Centile? A Retrospective Analysis in A Centre in North IndiaSemantic proximity Read ↗

The clinical impact of the first‐trimester nuchal translucency between the 95th–99th percentilesSemantic proximity Read ↗

Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study.Semantic proximity Read ↗

Quality Requirements for the early Fetal Ultrasound Assessment at 11–13+6 Weeks of Gestation (DEGUM Levels II and III)Semantic proximity Read ↗

Integrating NIPT and ultrasound for detecting fetal aneuploidies and abnormalitiesSemantic proximity Read ↗

Abnormal Nuchal Translucency and Outcomes of Singleton Pregnancies (Antop) Study: An 8 -year Retrospective Cohort AnalysisSemantic proximity Read ↗

‘Normal’ nuchal translucency: a justification to refrain from detailed scan? Analysis of 6858 cases with special reference to ethical aspectsSemantic proximity Read ↗

Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non‐invasive prenatal testing?Semantic proximity Read ↗

Elevated nuchal translucency, is it time to discuss the cut off?. A retrospective studySemantic proximity Read ↗

Cut‐off value of nuchal translucency as indication for chromosomal microarray analysisSemantic proximity Read ↗

Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort studySemantic proximity Read ↗

Chromosomal microarray in fetuses with increased nuchal translucencySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.